None listed
Conditions
Brief summary
This study will assessing the clinical utility of a calculated Survival Score Index for Implantable Cardioverter Defibrillator patients having had device battery replacement or palliative care at the Royal Adelaide Hospital. This study will retrospectively assess clinical parameters for patients who meet study inclusion citeria to allow calculation of a score for each individual, which will then be combined for group analysis of patients who had an intervention of battery replacement, or elective palliative deactivation of their device during the 5-year study period up until 31st December 2020.
Interventions
Patients at Royal Adelaide Hospital who have previously had intervention of their Implantable Cardioverter Defibrillator as either a battery replacement performed, or ellective palliative deactivation of the implant, between 1st January 2015 to 31st December 2020. Clinical parameters will be collected from medical records, and patients will not undergo any additional tests or clinical activities for this study. Differences in clinical parameters will be compared between patient groups and a previously reported Survival Score Index (Zoni-Berisso, et al. 2021 Heart Rhythm) will be utilised for comparison. The group who had ellective palliative deactivation of the implant will be our comparison group to define a cohort who has poor prognosis for life expectancy given palliative care.
Sponsors
Eligibility
Inclusion criteria
Implantable Cardioverter Defibrillator insitu which between January 1st 2015 to December 31st 2020 had at the Royal Adelaide Hospital an intervention of battery replacement or elective palliative deactivation performed.
Exclusion criteria
Cardiac Implantable Electronic Device is does not have Implantable Cardioverter Defibrillator function, or the intervention on the device was performed elsewhere.